Rxi IND Is A Go To Begin Phase 1/2 Trial For Scarring Of Macular Degeneration
September 01, 2015 at 20:40 PM EDT
RXi is on track to begin a phase 1/2 trial for retinal scarring of macular degeneration in the 4th quarter of 2015.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |